awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q52604161-CFFE97EE-EA87-4420-A01D-1C4E76D2D4FA
Q52604161-CFFE97EE-EA87-4420-A01D-1C4E76D2D4FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52604161-CFFE97EE-EA87-4420-A01D-1C4E76D2D4FA
Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis.
P2860
Q52604161-CFFE97EE-EA87-4420-A01D-1C4E76D2D4FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52604161-CFFE97EE-EA87-4420-A01D-1C4E76D2D4FA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
db80514e0d3721dbd0e491607c4fd12c5a2bbdb3
P2860
Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.